Study explains why Hepatitis B vaccine uptake is dismally low in India ...Middle East

News room odisha - News
Study explains why Hepatitis B vaccine uptake is dismally low in India
New Delhi, March 22 (IANS) Despite the availability of an effective vaccine against the Hepatitis B virus for over 30 years, its uptake has been low in India due to poor knowledge and lack of awareness, according to a study by Sir Ganga Ram Hospital. Hepatitis B virus (HBV) infection is a major global health issue, affecting around 296 million people globally and causing approximately 887,000 deaths yearly due to complications like liver end-stage liver cirrhosis and liver cancer. India has about “37 million HBV carriers”, said the researchers in the paper. Yet the knowledge about the disease as well of the preventive vaccine was found to be low. The team surveyed 3,500 participants, excludi

Hence then, the article about study explains why hepatitis b vaccine uptake is dismally low in india was published today ( ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study explains why Hepatitis B vaccine uptake is dismally low in India )

Apple Storegoogle play

Last updated :

Also on site :